{"id":9377,"date":"2022-07-28T15:51:49","date_gmt":"2022-07-28T13:51:49","guid":{"rendered":"https:\/\/immune.institute\/?p=9377"},"modified":"2026-02-20T09:50:49","modified_gmt":"2026-02-20T08:50:49","slug":"talento-tecnologico-centroamerica-becas-sica","status":"publish","type":"post","link":"https:\/\/immune.institute\/en\/blog\/talento-tecnologico-centroamerica-becas-sica\/","title":{"rendered":"IMMUNE, with the support of the SG-SICA, trains the technological talent of Central America and the Dominican Republic."},"content":{"rendered":"

Technology training and discovery technological talent<\/strong> anywhere in the world is one of our favourite things to do at IMMUNE. <\/p>\n\n\n\n

That is why today we are very pleased to announce the launch of a scholarship programme, in partnership with the General Secretariat of the Central American Integration System <\/strong>(SICA<\/a>) for Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Belize and the Dominican Republic.<\/p>\n\n\n\n

The objective? To encourage and building technological talent<\/strong> in the region and increase the employability of those who apply for one of these scholarships. <\/p>\n\n\n\n

Promoting employability and technological development<\/h2>\n\n\n\n

This was stated by Juan Riva<\/strong>CEO and founder of IMMUNE Technology Institute<\/a>:<\/p>\n\n\n\n

\n

\"Through these scholarships we hope to promote technological training in the region of Central America and the Dominican Republic in order to make these countries more competitive in this area\".<\/p>\n<\/blockquote>\n\n\n\n

The demand for technology profiles<\/strong> in the countries of Central America and the Dominican Republic<\/strong>As in Spain, it is still lower than the supply and, as a result, a large proportion of the vacancies needed by companies in the EU are still in short supply. remain uncovered.<\/strong><\/p>\n\n\n\n

In that sense, Juan Riva assures that:<\/p>\n\n\n\n

\n

\"The economic development of any country is directly dependent on the formation and, in the process of digital transformation<\/strong> The global situation we find ourselves in means that technological training is the key.\u00a0<\/p>\n<\/blockquote>\n\n\n\n

Grants for various technology programmes<\/h2>\n\n\n\n

In total, 72 people will benefit from these scholarships <\/strong>at Data Science<\/strong>, Cybersecurity<\/strong> y Cloud Computing with 12 months duration.<\/strong> To be eligible, you must be a national of one of the eight SICA Member States (Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Belize and the Dominican Republic). <\/p>\n\n\n\n

The programmes, which have a 100% online mode, <\/strong>and start on 7 November, are directed by professionals who are benchmarks in the sector <\/strong>within their respective technological areas. <\/p>\n\n\n\n

Interested parties can register now, and until 30 September<\/strong>through the IMMUNE website<\/strong><\/a>We are waiting for you!<\/p>\n\n\n\n

\n
\n
\n
\n
\n
Register here<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Formar en tecnolog\u00eda y descubrir talento tecnol\u00f3gico en cualquier parte del mundo es una de las cosas que m\u00e1s nos gusta hacer en IMMUNE. Por eso, hoy estamos muy contentos de anunciar el lanzamiento de un programa de becas, en colaboraci\u00f3n con la Secretar\u00eda General del Sistema de la Integraci\u00f3n Centroamericana (SICA) para Costa Rica, […]<\/p>\n","protected":false},"author":3,"featured_media":9414,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-9377","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"_links":{"self":[{"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/posts\/9377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/comments?post=9377"}],"version-history":[{"count":0,"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/posts\/9377\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/media\/9414"}],"wp:attachment":[{"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/media?parent=9377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/categories?post=9377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/immune.institute\/en\/wp-json\/wp\/v2\/tags?post=9377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}